Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 26

1.

Carbapenem-resistant Klebsiella pneumoniae in high-risk haematological patients: factors favouring spread, risk factors and outcome of carbapenem-resistant Klebsiella pneumoniae bacteremias.

Micozzi A, Gentile G, Minotti C, Cartoni C, Capria S, Ballarò D, Santilli S, Pacetti E, Grammatico S, Bucaneve G, Foà R.

BMC Infect Dis. 2017 Mar 10;17(1):203. doi: 10.1186/s12879-017-2297-9.

2.

Fully integrated ready-to-use paper-based electrochemical biosensor to detect nerve agents.

Cinti S, Minotti C, Moscone D, Palleschi G, Arduini F.

Biosens Bioelectron. 2017 Jul 15;93:46-51. doi: 10.1016/j.bios.2016.10.091. Epub 2016 Nov 1.

PMID:
27839735
3.

Independent prognostic impact of CD15 on complete remission achievement in patients with acute myeloid leukemia.

Chisini M, Stefanizzi C, Ceglie T, Raponi S, Vozella F, Colafigli G, Salaroli A, D'Angiò M, Mancini M, Diverio D, Breccia M, Mancini F, Minotti C, Trisolini S, Capria S, Testi AM, Guarini A, Latagliata R, De Propris MS, Foà R.

Hematol Oncol. 2017 Dec;35(4):804-809. doi: 10.1002/hon.2331. Epub 2016 Jul 12.

PMID:
27400753
4.

Posaconazole oral suspension primary prophylaxis in acute leukemia and allogeneic stem cell transplant patients: can it be used without measurement of plasma concentration?

Girmenia C, Annino L, Mariotti B, Fanci R, Minotti C, Spadea A, Carotti A, Piedimonte M, Chierichini A, Cerchiara E, Caselli D, Cupelli L, Arcioni F, Bertaina A, Ribersani M, Proia A, Mengarelli A, Perriello V, Torelli GF, Di Gioia M, Del Principe MI, Cassetta MI, Fallani S, Novelli A.

Med Mycol. 2016 Jul 1;54(5):445-58. doi: 10.1093/mmy/myw001. Epub 2016 Feb 11.

PMID:
26868905
5.

Introducing biological features at diagnosis improves the relapse risk stratification in patients with acute promyelocytic leukemia treated with ATRA and chemotherapy.

Breccia M, Stefania de Propris M, Molica M, Colafigli G, Minotti C, Diverio D, Latagliata R, Guarini A, Lo-Coco F, Foà R.

Am J Hematol. 2015 Sep;90(9):E181-2. doi: 10.1002/ajh.24033. Epub 2015 Jul 14. No abstract available.

6.

Catheter-associated bloodstream infections and thrombotic risk in hematologic patients with peripherally inserted central catheters (PICC).

Morano SG, Latagliata R, Girmenia C, Massaro F, Berneschi P, Guerriero A, Giampaoletti M, Sammarco A, Annechini G, Fama A, Di Rocco A, Chistolini A, Micozzi A, Molica M, Barberi W, Minotti C, Brunetti GA, Breccia M, Cartoni C, Capria S, Rosa G, Alimena G, Foà R.

Support Care Cancer. 2015 Nov;23(11):3289-95. doi: 10.1007/s00520-015-2740-7. Epub 2015 Apr 26.

PMID:
25910751
7.

Acute promyelocytic leukemia in patients aged >70 years: the cure beyond the age.

Finsinger P, Breccia M, Minotti C, Carmosino I, Girmenia C, Chisini M, Volpicelli P, Vozella F, Romano A, Montagna C, Colafigli G, Cimino G, Avvisati G, Petti MC, Lo-Coco F, Foà R, Latagliata R.

Ann Hematol. 2015 Feb;94(2):195-200. doi: 10.1007/s00277-014-2197-7. Epub 2014 Sep 4.

PMID:
25186786
8.

Pregnancy in acute promyelocytic leukaemia after front-line therapy with arsenic trioxide and all-trans retinoic acid.

Breccia M, Molica M, Efficace F, Minotti C, Latagliata R, Foà R, Lo Coco F.

Br J Haematol. 2014 Nov;167(3):428-30. doi: 10.1111/bjh.12995. Epub 2014 Jun 24. No abstract available.

PMID:
24957334
9.

Negative prognostic value of CD34 antigen also if expressed on a small population of acute promyelocytic leukemia cells.

Breccia M, De Propris MS, Stefanizzi C, Raponi S, Molica M, Colafigli G, Minotti C, Latagliata R, Diverio D, Guarini A, Foà R.

Ann Hematol. 2014 Nov;93(11):1819-23. doi: 10.1007/s00277-014-2130-0. Epub 2014 Jun 10.

PMID:
24912771
10.

Invasive fungal diseases during first induction chemotherapy affect complete remission achievement and long-term survival of patients with acute myeloid leukemia.

Girmenia C, Micozzi A, Piciocchi A, Gentile G, Di Caprio L, Nasso D, Minotti C, Capria S, Cartoni C, Alimena G, Meloni G, Amadori S, Foà R, Venditti A.

Leuk Res. 2014 Apr;38(4):469-74. doi: 10.1016/j.leukres.2014.01.007. Epub 2014 Jan 20.

PMID:
24534569
11.

Aberrant phenotypic expression of CD15 and CD56 identifies poor prognostic acute promyelocytic leukemia patients.

Breccia M, De Propris MS, Minotti C, Stefanizzi C, Raponi S, Colafigli G, Latagliata R, Guarini A, Foà R.

Leuk Res. 2014 Feb;38(2):194-7. doi: 10.1016/j.leukres.2013.11.008. Epub 2013 Nov 18.

PMID:
24296270
12.

Validation of a new proposed relapse risk score (CBC-score) for acute promyelocytic leukaemia.

Loglisci G, Minotti C, Serrao A, Molica M, Cicconi L, Saracino R, Breccia M.

Int J Hematol. 2014 Jan;99(1):100-1. doi: 10.1007/s12185-013-1438-1. Epub 2013 Sep 15. No abstract available.

PMID:
24037456
13.

Influence of time to complete remission and duration of all-trans retinoic acid therapy on the relapse risk in patients with acute promyelocytic leukemia receiving AIDA protocols.

Breccia M, Minotti C, Latagliata R, Loglisci G, Salaroli A, Loglisci MG, Lo-Coco F.

Leuk Res. 2013 Apr;37(4):383-5. doi: 10.1016/j.leukres.2012.11.014. Epub 2012 Dec 20.

PMID:
23259988
14.

Ara-C, Idarubicine and Gentuzumab Ozogamicin (AIM) as Salvage Treatment in Advanced Acute Myeloid Leukemia Patients.

Capria S, Trisolini SM, Minotti C, Stefanizzi C, Cardarelli L, Cartoni C, Diverio D, De Propris MS, Mancini M, Micozzi A, Foà R, Meloni G.

Mediterr J Hematol Infect Dis. 2012;4(1):e2012072. doi: 10.4084/MJHID.2012.072. Epub 2012 Nov 6.

15.

Atypical presentation of anaplastic large T-cell lymphoma mimicking an articular relapse of rheumatoid arthritis in a patient treated with etanercept. A case report and literature review.

De Angelis F, Di Rocco A, Minotti C, Valesini G, Cartoni C, Riminucci M, Conti F, Finolezzi E, Armiento D, Grammatico S, Massaro L, Fama A, Colafigli G, Viccarone C, Foà R, Martelli M.

Leuk Res. 2012 Sep;36(9):e199-201. doi: 10.1016/j.leukres.2012.06.004. Epub 2012 Jun 30. Review. No abstract available. Erratum in: Leuk Res. 2013 Oct;37(10):1393.

PMID:
22749557
16.

Posaconazole prophylaxis during front-line chemotherapy of acute myeloid leukemia: a single-center, real-life experience.

Girmenia C, Frustaci AM, Gentile G, Minotti C, Cartoni C, Capria S, Trisolini SM, Matturro A, Loglisci G, Latagliata R, Breccia M, Meloni G, Alimena G, Foà R, Micozzi A.

Haematologica. 2012 Apr;97(4):560-7. doi: 10.3324/haematol.2011.053058. Epub 2011 Nov 18.

17.

Increased BMI correlates with higher risk of disease relapse and differentiation syndrome in patients with acute promyelocytic leukemia treated with the AIDA protocols.

Breccia M, Mazzarella L, Bagnardi V, Disalvatore D, Loglisci G, Cimino G, Testi AM, Avvisati G, Petti MC, Minotti C, Latagliata R, Foà R, Pelicci PG, Lo-Coco F.

Blood. 2012 Jan 5;119(1):49-54. doi: 10.1182/blood-2011-07-369595. Epub 2011 Nov 2.

18.

Efficacy of prolonged therapy with combined arsenic trioxide and ATRA for relapse of acute promyelocytic leukemia.

Breccia M, Cicconi L, Minotti C, Latagliata R, Giannì L, Lo-Coco F.

Haematologica. 2011 Sep;96(9):1390-1. doi: 10.3324/haematol.2011.045500. Epub 2011 Jun 9. No abstract available.

19.

Thrombophilic screening in patients with paroxysmal nocturnal haemoglobinuria: a pilot study.

Dragoni F, Iori AP, Pignoloni P, Minotti C, Chiarotti F, Mazzucconi MG, Mengarelli A, Arcese W, Foà R, Avvisati G.

Br J Haematol. 2010 Aug;150(4):492-4. doi: 10.1111/j.1365-2141.2010.08230.x. Epub 2010 Jun 15. No abstract available.

PMID:
20560962
20.

Early hemorrhagic death before starting therapy in acute promyelocytic leukemia: association with high WBC count, late diagnosis and delayed treatment initiation.

Breccia M, Latagliata R, Cannella L, Minotti C, Meloni G, Lo-Coco F.

Haematologica. 2010 May;95(5):853-4. doi: 10.3324/haematol.2009.017962. Epub 2009 Dec 16. No abstract available.

21.

Clinically driven diagnostic antifungal approach in neutropenic patients: a prospective feasibility study.

Girmenia C, Micozzi A, Gentile G, Santilli S, Arleo E, Cardarelli L, Capria S, Minotti C, Cartoni C, Brocchieri S, Guerrisi V, Meloni G, Foà R, Martino P.

J Clin Oncol. 2010 Feb 1;28(4):667-74. doi: 10.1200/JCO.2009.21.8032. Epub 2009 Oct 19.

PMID:
19841328
22.

An acute promyelocytic leukaemia patient with a new atypical promyelocytic leukemia breakpoint.

Cenfra N, De Cave F, Minotti C, Ghia E, Rago A, Codacci Pisanelli G, Diverio D, Cimino G.

Br J Haematol. 2008 Sep;142(5):854-6. doi: 10.1111/j.1365-2141.2008.07253.x. No abstract available.

PMID:
18573113
23.

Prolonged molecular remission in a newly diagnosed acute promyelocytic leukaemia with a severe cardiomyopathy using low-dose gemtuzumab ozogamicin and all-trans retinoic acid.

Martini V, Minotti C, Breccia M, De Angelis G, Buffolino S, Mariella M, Lo-Coco F, Avvisati G, Cimino G.

Ann Hematol. 2007 Apr;86(4):295-7. Epub 2006 Nov 30. No abstract available.

PMID:
17136541
24.

As compared to kaolin clotting time, silica clotting time is a specific and sensitive automated method for detecting lupus anticoagulant.

Dragoni F, Minotti C, Palumbo G, Faillace F, Redi R, Bongarzoni V, Avvisati G.

Thromb Res. 2001 Jan 15;101(2):45-51.

PMID:
11342205
25.

High levels of antiphospholipid antibodies are associated with cytomegalovirus infection in unrelated bone marrow and cord blood allogeneic stem cell transplantation.

Mengarelli A, Minotti C, Palumbo G, Arcieri P, Gentile G, Iori AP, Arcese W, Mandelli F, Avvisati G.

Br J Haematol. 2000 Jan;108(1):126-31.

PMID:
10651735
26.

The management of acute myelogenous leukemia in the elderly: ten-year experience in 118 patients.

Bassan R, Buelli M, Viero P, Minotti C, Barbui T.

Hematol Oncol. 1992 Sep-Oct;10(5):251-60.

PMID:
1493909

Supplemental Content

Loading ...
Support Center